Not a good buy right now for an impatient investor: momentum is still bearish (MACD negative and worsening) and price is below the key pivot (93.10).
Better risk/reward appears only if it either (a) cleanly reclaims 93.10+ and holds, or (b) flushes to/near 86.94 (S2) and stabilizes—neither is confirmed today.
Near-term upside catalysts exist (new contract, supportive analyst view), but fundamentals are currently contracting YoY and earnings are upcoming (2026-02-26), which can keep the stock choppy.
Trend/momentum: Bearish-to-neutral. MACD histogram at -0.823 (below zero and negatively expanding) indicates downside momentum is still building.
RSI: RSI(6) ~39.7, weak but not deeply oversold; suggests downside pressure with room for further selling before a strong mean-reversion signal.
Moving averages: Converging MAs = indecision/transition, but with MACD bearish this favors a weak/bearish bias until price proves otherwise.
Key levels:
Support: 89.29 (S1) is close to current price (~90.7); a break increases odds of testing 86.94 (S2).
Resistance/Pivot: 93.10 pivot is the key “line in the sand” for trend improvement; above that, next resistance is 96.92 (R1).
Pattern-based outlook (provided): ~+6.53% next week but ~-1.27% next month—fits a potential short bounce inside a broader soft trend.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning: OI put/call at 0.41 is relatively bullish (more call open interest than puts), suggesting market participants are leaning to upside/hedging less.
Activity: Today’s option volume is effectively 0, so the sentiment signal is more about existing positioning than fresh conviction.
Volatility: 30D IV ~42.34 vs historical vol ~31.74; IV percentile ~68.5 suggests options are priced relatively rich, often seen ahead of catalysts (earnings on 2026-02-26).
Technical Summary
Sell
8
Buy
6
Positive Catalysts
can attract dip buyers if support holds.
Neutral/Negative Catalysts
increases risk that rallies fade until growth re-accelerates.
Financial Performance
Latest quarter provided: 2025/Q3.
Revenue: $465.4M, down ~9.98% YoY (top-line contraction).
Net income: $23.77M, down ~27.27% YoY (profitability pressure).
EPS: $1.28, down ~26.01% YoY (earnings decline sharper than revenue).
Gross margin: 34.53%, down ~0.17% YoY (slightly weaker; not collapsing, but not improving either).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent notable change: (2025-12-02) Canaccord upgraded ICFI to Buy from Hold; raised price target to $115 from $90.
Wall Street pros view (bull case): Setbacks framed as cyclical; ICF’s government-linked franchise and full lifecycle services position it for continued demand as policy/program complexity rises.
Wall Street cons view (bear case): High exposure to U.S. federal government work (noted as ~43% of sales) can amplify budget/timing disruption risk; recent results show real YoY contraction.
Influential/political trading: No recent congress trading data available; hedge funds and insiders show neutral recent activity (no strong accumulation signal).
Wall Street analysts forecast ICFI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ICFI is 99.67 USD with a low forecast of 82 USD and a high forecast of 115 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast ICFI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ICFI is 99.67 USD with a low forecast of 82 USD and a high forecast of 115 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 88.340
Low
82
Averages
99.67
High
115
Current: 88.340
Low
82
Averages
99.67
High
115
Canaccord
Hold
to
Buy
upgrade
$90 -> $115
AI Analysis
2025-12-02
Reason
Canaccord
Price Target
$90 -> $115
AI Analysis
2025-12-02
upgrade
Hold
to
Buy
Reason
Canaccord upgraded ICF International to Buy from Hold with a price target of $115, up from $90, following a transfer of coverage. The company saw "major setbacks" in 2025 as 43% of its sales are tied to the U.S. federal government, the analyst tells investors in a research note. Canaccord believes the value of ICF's "resilient franchise" is being "obscured by cyclical rather than structural challenges." The firm says the company "delivers value across the full life cycle of policies, programs, projects, and initiatives for a diverse client base." It thinks ICF is set for continued strong demand as governments and businesses "face evolving challenges."
Barrington
Barrington
Outperform
maintain
$102 -> $107
2025-08-11
Reason
Barrington
Barrington
Price Target
$102 -> $107
2025-08-11
maintain
Outperform
Reason
Barrington raised the firm's price target on ICF International to $107 from $102 and keeps an Outperform rating on the shares post the Q2 report. The firm increased profitability forecasts citing signs of stabilization in the company's federal business and growth in its commercial energy segment.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ICFI
